SignNow Review (2026): Enterprise-Grade Signing at Mid-Market Prices

If your company has more than one person sending documents for signature, airSlate SignNow was probably built with you in mind. This isn't a tool for freelancers firing off the occasional NDA — it's a team-scale signing infrastructure developed by airSlate, the workflow automation company behind a product suite trusted by 28 million+ users. SignNow occupies a very specific market position: everything DocuSign does at the enterprise level, available to mid-market teams at roughly a third of the cost.

The onboarding tells you exactly what kind of product this is. Within the first three minutes, you're not just placing signature fields — you're assigning color-coded recipients, setting signing order, choosing whether certain fields appear conditionally, and configuring kiosk mode for in-person collections. The depth of configuration available on first contact is striking. This is not a "sign and send" tool — it's a document workflow orchestrator that happens to start with signatures.

The legal and compliance infrastructure is where SignNow flexes hardest. SOC 2 Type II certification (not just Type I — the distinction matters, as Type II requires sustained compliance over a reporting period). ESIGN Act, UETA, and eIDAS for multi-jurisdictional legal validity. GDPR for European data handling. And on the Site License tier (advanced compliance standards): HIPAA for healthcare and 21 CFR Part 11 for pharmaceutical companies subject to FDA electronic signature regulations. That last one is particularly rare — most mid-market competitors don't even acknowledge 21 CFR Part 11 exists.

The integration story is where SignNow pulls ahead of lighter competitors. Native Salesforce integration. Google Workspace. Microsoft 365. Netsuite. Autodesk. A developer-ready REST API with its own sandbox environment and 250 free signature invitations for testing. For teams that live inside CRM and ERP systems, this isn't a nice-to-have — it's the reason SignNow makes the shortlist while other platforms don't.

Where SignNow belongs in your stack

SignNow is built for the 20-to-500 person company that has outgrown basic signing tools but isn't ready to commit to DocuSign's enterprise pricing. Sales teams closing deals through Salesforce. HR departments processing offer letters and benefits forms at scale. Healthcare organizations that need HIPAA without a six-figure platform commitment. Real estate firms with agents in the field collecting signatures on tablets. If your bottleneck is "too many documents, too many stakeholders, not enough automation," SignNow is the platform that solves that problem without requiring a procurement committee to approve the purchase.

SignNow's pricing model reflects its positioning: this is a team platform priced for teams, not a per-envelope trap. The standout shift in recent years is the move to unlimited users on all paid plans — businesses pay based on signature volume rather than headcount. That's a fundamentally different economic model from DocuSign, and for growing teams it can mean the difference between $500/month and $50/month.

• Business: $8/month flat (annual) — The foundation. Unlimited users, 100 signature invites per year, reusable templates, mobile apps, basic cloud storage. Sufficient for small teams with moderate signing volume.
• Business Premium: $15/month flat (annual) — Where SignNow gets serious. Keeps the 100-invite cap and adds bulk send, invite links, payment requests, auto-reminders, team template collaboration, and branded experiences. The most popular tier for growing sales and operations teams.
• Enterprise: $30/month flat (annual) — Recipient identity verification, conditional show/hide fields, file upload requests, redirect actions, and SMS invites. Still capped at 100 invites/year. For teams handling sensitive or complex multi-page agreements.
• Site License: $1.50 per signature invite (volume discounts) — The unlimited-volume tier. Pay-per-invite economics with full API access, CRM integrations (Salesforce, NetSuite), SSO, advanced compliance (HIPAA, 21 CFR Part 11), and phone support. Built for high-volume teams and regulated industries.

Monthly billing is available at a notably higher rate (the pricing page advertises up to 60% savings on annual). A 7-day free trial requires no credit card. After 100 signature invites per year on the workspace, teams must upgrade to Site License (pay-per-invite at $1.50, volume discounts apply) — a critical detail for high-volume teams to model before committing. Current pricing should always be verified on the official website.

SignNow's security posture reflects its parent company's enterprise ambitions. airSlate has invested in the kind of security infrastructure you'd expect from a platform serving Fortune 500 companies — and then made it available to mid-market teams at mid-market prices.

The encryption implementation is standard but solid: AES-256 at rest, TLS 1.2+ in transit. Documents reside in SOC 2-audited data centers engineered for redundancy, with automated failover and disaster recovery. Nothing flashy here — just the baseline done correctly.

Where SignNow distinguishes itself is in authentication depth. Most competitors offer one or two signer verification methods. SignNow provides four: email verification, SMS one-time codes, password-gated access, and phone call confirmation. The Enterprise plan layers on advanced threat protection — behavioral analysis and anomaly detection designed to catch unauthorized access before it reaches documents.

The compliance portfolio is the strongest in this price segment. SOC 2 Type II — not Type I, meaning auditors verified sustained operational compliance over time, not just a point-in-time snapshot. GDPR compliance for European operations. And on the Site License plan, two regulatory certifications that few mid-market platforms carry: HIPAA for healthcare organizations (with proper BAA arrangements), and 21 CFR Part 11 for life sciences companies operating under FDA electronic signature requirements. That 21 CFR Part 11 credential alone eliminates most of SignNow's competitors from pharmaceutical and clinical trial use cases.

Additional enterprise controls include SSO integration, role-based team permissions, and organizational access policies. airSlate also maintains a public Bug Bounty Program, inviting external researchers to test the platform's defenses continuously.